The burden of intracranial atherosclerosis on cerebral small vessel disease: A community cohort study

Joseph Amihere Ackah1, Heng Du2, Wenjie Yang3

  • 1Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Kowloon, Hong Kong, SAR, China.

Insights

Intracranial atherosclerosis (ICAS) and cerebral small vessel diseases (CSVD) show a dose-effect relationship, not just shared risk factors. High-resolution vessel wall MRI (HRVW-MRI) reveals how ICAS impacts CSVD burdens, aiding clinical decisions.

Area of Science:

  • Neuroimaging
  • Vascular Neurology
  • Cardiovascular Research

Background:

  • Cerebral small vessel diseases (CSVD) and intracranial atherosclerosis (ICAS) are common in aging populations.
  • Their association is often attributed to shared risk factors, but underlying mechanisms require further investigation.
  • High-resolution vessel wall MRI (HRVW-MRI) offers detailed insights into atherosclerotic plaque characteristics.

Purpose of the Study:

  • To explore the prevalence and association between ICAS and CSVD using HRVW-MRI.
  • To investigate how subtle changes in intracranial atherosclerotic features influence CSVD burdens.
  • To determine if a dose-effect relationship exists between ICAS and CSVD.

Main Methods:

  • Recruitment of stroke-free Chinese adults from a community-based MRI cohort.
  • Assessment of ICAS features (plaque load, stenosis, remodelling, eccentricity) using HRVW-MRI.
  • Evaluation of CSVD markers (white matter hyperintensities, lacunes, microbleeds, enlarged perivascular spaces) via multi-sequence MRI.
  • Statistical analyses including correlation and regression models to assess ICAS-CSVD association.

Main Results:

  • Out of 225 participants, 17.3% had ICAS and 47.1% had at least one significant CSVD marker.
  • Subtle changes in ICAS features (positive remodelling, plaque load, eccentricity, stenosis) correlated with distinct CSVD markers and overall burden.
  • A dose-effect relationship between ICAS severity and CSVD burden was suggested.

Conclusions:

  • The association between ICAS and CSVD is more than co-existence; a dose-effect relationship is likely.
  • HRVW-MRI can identify diagnostic metrics and features showing ICAS's impact on CSVD.
  • Findings enhance understanding and clinical decision-making for patients with ICAS and CSVD.
Abstract

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.5K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
961
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
747
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
592
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
53
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
68